Revascularization and Digestive Tract Repair in Secondary Aortoenteric Fistula Using a Single-center In situ Revascularization Strategy.

abdominal aorta in situ revascularization prosthetic graft infection secondary aortoenteric fistula

Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
28 Dec 2023
Historique:
received: 07 03 2023
revised: 31 07 2023
accepted: 22 10 2023
medline: 2 1 2024
pubmed: 2 1 2024
entrez: 30 12 2023
Statut: aheadofprint

Résumé

Information regarding optimal revascularization and digestive tract repair in secondary aortoenteric fistula (sAEF) remains unclear. Thus, reporting treatment outcomes and presenting comprehensive patient details through a structured treatment approach are necessary to establish a treatment strategy for this rare, complex, and fatal condition. We performed a single-center retrospective review of consecutive sAEF managed based on our in situ revascularization (ISR) and intestinal repair strategy. The primary endpoint of this study was all-cause mortality, and secondary endpoints were the incidence of in-hospital complications and midterm reinfections. Between 2007 and 2020, 16 patients with sAEF, including 13 men (81%), underwent ISR and digestive tract repair. The median follow-up duration for all participants was 36 (interquartile range, 6-62) months. Among the participants, 81% (n = 13), 13% (n = 2), and 6% (n = 1) underwent aortic reconstruction with rifampin-soaked grafts, unsoaked Dacron grafts, and femoral veins, respectively. The duodenum was the most commonly involved site in enteric pathology (88%; n = 14), and 57% (n = 8) of duodenal breaks were repaired by a simple closure. Duodenum second part-jejunum anastomosis was performed in 43% of patients (n = 6), and perioperatively, 19% of the patients (n = 3) died. In-hospital complications occurred in 88% patients (n = 14), and the most frequent complication was gastrointestinal. Finally, 81% patients (n = 13) were discharged home. Oral antibiotics were administered for a median duration of 5.7 months postoperatively; subsequently, the participants were followed up carefully. Reinfection was detected in 6% of the patients (n = 1) who underwent reoperation without any complications. The 1- and 3-year overall survival rates of participants were 75% (n = 12) and 75% (n = 9), respectively, and no sAEF-related deaths occurred, except perioperative death. Surgical intervention with contemporary management based on our vascular strategy and digestive tract procedure may be a durable treatment for sAEF.

Identifiants

pubmed: 38159719
pii: S0890-5096(23)00856-7
doi: 10.1016/j.avsg.2023.10.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Daijirou Akamatsu (D)

Tohoku University Hospital, Sendai, Japan. Electronic address: daijirou@surg.med.tohoku.ac.jp.

Fukashi Serizawa (F)

Tohoku University Hospital, Sendai, Japan.

Michihisa Umetsu (M)

Tohoku University Hospital, Sendai, Japan.

Shunya Suzuki (S)

Tohoku University Hospital, Sendai, Japan.

Hitoshi Goto (H)

South Miyagi Medical Center, Shibata, Japan.

Michiaki Unno (M)

Tohoku University Hospital, Sendai, Japan.

Takashi Kamei (T)

Tohoku University Hospital, Sendai, Japan.

Classifications MeSH